Status:
RECRUITING
A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Anemia
Decreased Glomerular Filtration Rate
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to measure the evidence-based intervention's (EBIs) impact on patient safety and efficiency, to assess the EBIs implementation by measuring acceptability, appropriateness,...
Eligibility Criteria
Primary care providers' inclusion criteria:
- physicians, physicians assistants and advanced practice registered nurses in the 13 clinic locations of UTP are eligible if they care for patients at the time patient enrollment at their clinic begins
- agree to participate.
Patients' inclusion criteria are:
- hemoglobin result < 10.8 for females and < 12.5 for males with normal white cell count and platelet count (the prior hemoglobin results must have been in normal range, with a look-back period of two years)
- an eGFR value < 60 (the prior eGFR results must have been in normal range, with a look-back range of two years)
- the matching creatinine results must also be in normal range
- not pregnant
- speak English or Spanish.
Key Trial Info
Start Date :
January 8 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 16 2026
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT05735314
Start Date
January 8 2024
End Date
July 16 2026
Last Update
December 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Health Science Center at Houston
Houston, Texas, United States, 77030